SEP 17, 2016 8:56 AM PDT

Inhibiting the Autoimmune Response to Treat Multiple Sclerosis

WRITTEN BY: Kara Marker
Treatment options for autoimmune diseases like multiple sclerosis (MS) are complicated, because inhibiting the immune system to prevent neural damage simultaneously makes the patient extremely vulnerable to dangerous infections. New research from the University of Maryland aims to bypass the negative side effects while still inhibiting the autoimmune response that leads to the debilitating fatigue, disturbed sensation, and mobility problems associated with MS.
In the words of corresponding author and assistant professor Christopher Jewell, their aim is to “reprogram how the immune system responds to self-cells in the brain that are mistakenly attacked during MS.”

For MS, type 1 diabetes, and other autoimmune diseases with no existing cure, the Maryland scientists present a combination of immunology and nanotechnology that could inhibit the autoimmune responses that causes disease and leave the healthy function of the immune system up and running. 

Together, the team of scientists created biodegradable polymers that deliver regulatory signals to the lymph nodes upon injection, prompting the immune organs to produce regulatory immune cells as opposed to autoimmune cells that attack myelin, the insulator and protector of neurons in the brain. 

“The hope is that these cells can directly suppress inflammation without targeting healthy immune function,” said first author Lisa Tostanoski. The team saw initial success in polymer delivery in both cell models and pre-clinical animal models of MS: they demonstrated that a single treatment of biodegradable particles could completely and permanently reverse paralysis from MS.

"This innovative research has the potential to open up a new, highly selective approach to treating multiple sclerosis," said Bruce F. Bebo, Ph.D., Executive Vice President of Research at the National Multiple Sclerosis Society, which funded the Maryland study.

MS affects more than two million people across the globe, with symptoms ranging from mild to complete paralysis. 

The study was recently published in the journal Cell Reports.
 


Sources: National Multiple Sclerosis Society, University of Maryland
Images: nutriunify.com, www.kevinmd.com
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 07, 2021
Microbiology
Positive Results From A Clinical Trial of an HIV Vaccine
FEB 07, 2021
Positive Results From A Clinical Trial of an HIV Vaccine
After years of effort, researchers are reporting that there were encouraging results from a phase 1 clinical trial which ...
APR 03, 2021
Cancer
New factor plays a key role in immune response
APR 03, 2021
New factor plays a key role in immune response
In a study published recently in Science Immunology, WEHI’s Professor Stephen Nutt, Dr. Michael Chopin, and Mr. Sh ...
APR 21, 2021
Immunology
Human T Cells Can't Recognize COVID Mutants
APR 21, 2021
Human T Cells Can't Recognize COVID Mutants
Genetic variants of the SARS-CoV-2 virus have emerged and tightened their grip on global communities as the pandemic rag ...
APR 27, 2021
Immunology
Breakthrough Malaria Vaccine Is a Ray of Hope
APR 27, 2021
Breakthrough Malaria Vaccine Is a Ray of Hope
University of Oxford scientists have developed a vaccine against malaria, which they describe as having “unprecede ...
MAY 11, 2021
Immunology
Immune Cells Help Brain Tumors Spread, but We Can Stop Them
MAY 11, 2021
Immune Cells Help Brain Tumors Spread, but We Can Stop Them
Researchers have discovered how a glitch in the brain’s immune system can inadvertently cause an accelerated growt ...
JUN 11, 2021
Cell & Molecular Biology
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
JUN 11, 2021
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
The immune system can detect and destroy pathogenic and cancerous cells, but sometimes those dangerous cells can evade t ...
Loading Comments...